Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000147

Director sold 1,666 shares at $19.13 ($31,871)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2023-11-15 Sale 10b5-1 −1,666 $19.13 $31,871 126,373 D: show line 1 in the form
Open-market sales · 1,666 sh · avg $19.13 · $31,871
Loading xslF345X05/wk-form4_1700176428.xml…